Copyright Reports & Markets. All rights reserved.

Global G-CSF Biosimilars Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of G-CSF Biosimilars

      • 1.1 Definition of G-CSF Biosimilars
      • 1.2 G-CSF Biosimilars Segment by Type
        • 1.2.1 Global G-CSF Biosimilars Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Human Growth Hormone
        • 1.2.3 Erythropoietin
        • 1.2.4 Monoclonal Antibodies
        • 1.2.5 Insulin
        • 1.2.6 Interferon
        • 1.2.7 Granulocyte-Colony Stimulating Factor
      • 1.3 G-CSF Biosimilars Segment by Applications
        • 1.3.1 Global G-CSF Biosimilars Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Blood Disorders
        • 1.3.3 Oncology Diseases
        • 1.3.4 Chronic And Autoimmune Diseases
        • 1.3.5 Growth Hormone Deficiencies
      • 1.4 Global G-CSF Biosimilars Overall Market
        • 1.4.1 Global G-CSF Biosimilars Revenue (2014-2025)
        • 1.4.2 Global G-CSF Biosimilars Production (2014-2025)
        • 1.4.3 North America G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.4 Europe G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.5 China G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.6 Japan G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.8 India G-CSF Biosimilars Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of G-CSF Biosimilars
      • 2.3 Manufacturing Process Analysis of G-CSF Biosimilars
      • 2.4 Industry Chain Structure of G-CSF Biosimilars

      3 Development and Manufacturing Plants Analysis of G-CSF Biosimilars

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global G-CSF Biosimilars Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of G-CSF Biosimilars
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 G-CSF Biosimilars Production and Capacity Analysis
      • 4.2 G-CSF Biosimilars Revenue Analysis
      • 4.3 G-CSF Biosimilars Price Analysis
      • 4.4 Market Concentration Degree

      5 G-CSF Biosimilars Regional Market Analysis

      • 5.1 G-CSF Biosimilars Production by Regions
        • 5.1.1 Global G-CSF Biosimilars Production by Regions
        • 5.1.2 Global G-CSF Biosimilars Revenue by Regions
      • 5.2 G-CSF Biosimilars Consumption by Regions
      • 5.3 North America G-CSF Biosimilars Market Analysis
        • 5.3.1 North America G-CSF Biosimilars Production
        • 5.3.2 North America G-CSF Biosimilars Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America G-CSF Biosimilars Import and Export
      • 5.4 Europe G-CSF Biosimilars Market Analysis
        • 5.4.1 Europe G-CSF Biosimilars Production
        • 5.4.2 Europe G-CSF Biosimilars Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe G-CSF Biosimilars Import and Export
      • 5.5 China G-CSF Biosimilars Market Analysis
        • 5.5.1 China G-CSF Biosimilars Production
        • 5.5.2 China G-CSF Biosimilars Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China G-CSF Biosimilars Import and Export
      • 5.6 Japan G-CSF Biosimilars Market Analysis
        • 5.6.1 Japan G-CSF Biosimilars Production
        • 5.6.2 Japan G-CSF Biosimilars Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan G-CSF Biosimilars Import and Export
      • 5.7 Southeast Asia G-CSF Biosimilars Market Analysis
        • 5.7.1 Southeast Asia G-CSF Biosimilars Production
        • 5.7.2 Southeast Asia G-CSF Biosimilars Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia G-CSF Biosimilars Import and Export
      • 5.8 India G-CSF Biosimilars Market Analysis
        • 5.8.1 India G-CSF Biosimilars Production
        • 5.8.2 India G-CSF Biosimilars Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India G-CSF Biosimilars Import and Export

      6 G-CSF Biosimilars Segment Market Analysis (by Type)

      • 6.1 Global G-CSF Biosimilars Production by Type
      • 6.2 Global G-CSF Biosimilars Revenue by Type
      • 6.3 G-CSF Biosimilars Price by Type

      7 G-CSF Biosimilars Segment Market Analysis (by Application)

      • 7.1 Global G-CSF Biosimilars Consumption by Application
      • 7.2 Global G-CSF Biosimilars Consumption Market Share by Application (2014-2019)

      8 G-CSF Biosimilars Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer G-CSF Biosimilars Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis G-CSF Biosimilars Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Roche
        • 8.3.1 Roche G-CSF Biosimilars Production Sites and Area Served
        • 8.3.2 Roche Product Introduction, Application and Specification
        • 8.3.3 Roche G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Merck & Co.
        • 8.4.1 Merck & Co. G-CSF Biosimilars Production Sites and Area Served
        • 8.4.2 Merck & Co. Product Introduction, Application and Specification
        • 8.4.3 Merck & Co. G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Sanofi
        • 8.5.1 Sanofi G-CSF Biosimilars Production Sites and Area Served
        • 8.5.2 Sanofi Product Introduction, Application and Specification
        • 8.5.3 Sanofi G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson & Johnson
        • 8.6.1 Johnson & Johnson G-CSF Biosimilars Production Sites and Area Served
        • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.6.3 Johnson & Johnson G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Gilead Science
        • 8.7.1 Gilead Science G-CSF Biosimilars Production Sites and Area Served
        • 8.7.2 Gilead Science Product Introduction, Application and Specification
        • 8.7.3 Gilead Science G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 GlaxoSmithKline
        • 8.8.1 GlaxoSmithKline G-CSF Biosimilars Production Sites and Area Served
        • 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.8.3 GlaxoSmithKline G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 AbbVie
        • 8.9.1 AbbVie G-CSF Biosimilars Production Sites and Area Served
        • 8.9.2 AbbVie Product Introduction, Application and Specification
        • 8.9.3 AbbVie G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amgen
        • 8.10.1 Amgen G-CSF Biosimilars Production Sites and Area Served
        • 8.10.2 Amgen Product Introduction, Application and Specification
        • 8.10.3 Amgen G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 AstraZeneca
      • 8.12 Bayer

      9 Development Trend of Analysis of G-CSF Biosimilars Market

      • 9.1 Global G-CSF Biosimilars Market Trend Analysis
        • 9.1.1 Global G-CSF Biosimilars Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 G-CSF Biosimilars Regional Market Trend
        • 9.2.1 North America G-CSF Biosimilars Forecast 2019-2025
        • 9.2.2 Europe G-CSF Biosimilars Forecast 2019-2025
        • 9.2.3 China G-CSF Biosimilars Forecast 2019-2025
        • 9.2.4 Japan G-CSF Biosimilars Forecast 2019-2025
        • 9.2.5 Southeast Asia G-CSF Biosimilars Forecast 2019-2025
        • 9.2.6 India G-CSF Biosimilars Forecast 2019-2025
      • 9.3 G-CSF Biosimilars Market Trend (Product Type)
      • 9.4 G-CSF Biosimilars Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 G-CSF Biosimilars Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
        The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
        This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
        Company profiles are primarily based on public domain information including company
        Merck & Co.
        Sanofi
        Johnson & Johnson
        Gilead Science
        GlaxoSmithKline
        AbbVie
        Amgen
        AstraZeneca
        Bayer
        Pfizer
        Novartis
        Roche

        The global G-CSF Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF Biosimilars market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of G-CSF Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their G-CSF Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Roche
        Merck & Co.
        Sanofi
        Johnson & Johnson
        Gilead Science
        GlaxoSmithKline
        AbbVie
        Amgen
        AstraZeneca
        Bayer

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Human Growth Hormone
        Erythropoietin
        Monoclonal Antibodies
        Insulin
        Interferon
        Granulocyte-Colony Stimulating Factor

        Segment by Application
        Blood Disorders
        Oncology Diseases
        Chronic And Autoimmune Diseases
        Growth Hormone Deficiencies

        Buy now